| Hans-Günter Meyer-Thompson | Diamorphin
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling).
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling).
Dobischok S, Metcalfe R, Matzinger E, Palis H, Marchand K, Harrison S, MacDonald S, Byres D, Schechter M, Bansback N, Oviedo-Joekes E.
Int J Drug Policy. 2022 Dec 29;112:103948. doi: 10.1016/j.drugpo.2022.103948. Epub ahead of print. PMID: 36586152.
https://www.sciencedirect.com/science/article/abs/pii/S0955395922003644